Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Pharmaceutisch Weekblad. Scientific Edition
|
April 24, 1992
Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways
M L Bouvy, M C Sturkenboom, M C Cornel, et al.
Prenatal Diagnosis
|
October 4, 2000
Trends in live birth prevalence of down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosis
M J Wortelboer, B T De Wolf, C C Verschuuren-Bemelmans, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 14, 2022
Endometrial cancer after endometrial ablation: a systematic review
Tamara J Oderkerk, Mileen R D van de Kar, Karlijn M C Cornel, et al.
Journal of Epidemiology and Community Health
|
September 1, 1988
Frequency of births with potentially avoidable serious chromosomal anomalies in EEC countries, 1979-1982
L P Ten Kate, H Dolk, M C Cornel, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Ad hoc tracing of a cohort of patients exposed to acitretine (Neotigason) on a nation-wide scale
B H Stricker, M Barendregt, R M Herings, et al.
Paediatric and Perinatal Epidemiology
|
October 1, 1991
Association between holoprosencephaly and exposure to topical retinoids: results of the EUROCAT Survey
P De Wals, D Bloch, A Calabro, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 25, 1991
[Acitretin; an example of ad-hoc tracing of users in acute problems with drugs]
B H Stricker, M Barendregt, R M Herings, et al.
European Journal of Human Genetics : EJHG
|
April 26, 2000
Accuracy of family history of cancer: clinical genetic implications
R H Sijmons, A E Boonstra, J Reefhuis, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
July 14, 1990
[Indications for an increased risk of neural tube defects in pregnancies following ovulation induction and (or) in-vitro fertilization]
M C Cornel, L T de Jong-van den Berg, J Koudstaal, et al.
British Journal of Clinical Pharmacology
|
September 1, 1994
Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment
M C Sturkenboom, L T de Jong-Van Den Berg, P C van Voorst-Vader, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Pharmaceutisch Weekblad. Scientific Edition
|
April 24, 1992
Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways
M L Bouvy, M C Sturkenboom, M C Cornel, et al.
Prenatal Diagnosis
|
October 4, 2000
Trends in live birth prevalence of down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosis
M J Wortelboer, B T De Wolf, C C Verschuuren-Bemelmans, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 14, 2022
Endometrial cancer after endometrial ablation: a systematic review
Tamara J Oderkerk, Mileen R D van de Kar, Karlijn M C Cornel, et al.
Journal of Epidemiology and Community Health
|
September 1, 1988
Frequency of births with potentially avoidable serious chromosomal anomalies in EEC countries, 1979-1982
L P Ten Kate, H Dolk, M C Cornel, et al.
European Journal of Clinical Pharmacology
|
January 1, 1992
Ad hoc tracing of a cohort of patients exposed to acitretine (Neotigason) on a nation-wide scale
B H Stricker, M Barendregt, R M Herings, et al.
Paediatric and Perinatal Epidemiology
|
October 1, 1991
Association between holoprosencephaly and exposure to topical retinoids: results of the EUROCAT Survey
P De Wals, D Bloch, A Calabro, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 25, 1991
[Acitretin; an example of ad-hoc tracing of users in acute problems with drugs]
B H Stricker, M Barendregt, R M Herings, et al.
European Journal of Human Genetics : EJHG
|
April 26, 2000
Accuracy of family history of cancer: clinical genetic implications
R H Sijmons, A E Boonstra, J Reefhuis, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
July 14, 1990
[Indications for an increased risk of neural tube defects in pregnancies following ovulation induction and (or) in-vitro fertilization]
M C Cornel, L T de Jong-van den Berg, J Koudstaal, et al.
British Journal of Clinical Pharmacology
|
September 1, 1994
Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment
M C Sturkenboom, L T de Jong-Van Den Berg, P C van Voorst-Vader, et al.
Page
of 11